Toronto Stock Exchange Symbol: LRI
LAVAL, QC, Feb. 9 /CNW Telbec/ - LAB Research Inc. (TSX: LRI) ("LAB
Research" or the "Company"), a Canadian based global non-clinical contract
research organization ("CRO"), today announced that Mr. Luc Mainville, Chief
Executive Officer of the Company, will be presenting at the UBS 2009 Global
Healthcare Services Conference on Wednesday February 11, 2009 at 9.30 am at
the Waldorf Astoria Hotel in New York.
A live webcast of the presentation will be available on LAB Research
website in the Investors section at www.labresearch.com
About LAB Research Inc.:
LAB Research is a Canadian global non-clinical contract research
organization that provides contract research services to the pharmaceutical,
biotechnology, agro-chemical, petro-chemical and industrial markets. LAB
Research supports the development of its customers' products from three
state-of-the-art facilities located in Canada, Denmark and Hungary.
LAB Research's shares trade on The Toronto Stock Exchange ("TSX") under
the symbol "LRI", with 18.1 million shares outstanding.
This news release contains certain forward-looking statements that
reflect the current views and/or expectations of LAB Research Inc. with
respect to its performance, business and future events. Such statements are
subject to a number of risks, uncertainties and assumptions. Actual results
and events may vary significantly.
For further information:
For further information: visit LAB Research's website at
www.labresearch.com, or contact: Luc Mainville, Chief Executive Officer, (450)
973-2240, (ext. 1206), email@example.com; Frédéric Dumais,
Jasmin-Dumais Financial Communications, (514) 862-1251, firstname.lastname@example.org